Eye Health Supplements Market is estimated to be valued at USD 3,257.1 Mn in 2025 and is expected to reach USD 5,474.5 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.
The global Eye Health Supplements Market is experiencing steady growth, fuelled by rising incidences of age-related vision disorders such as macular degeneration and cataracts. Increasing awareness of preventive eye care and the benefits of nutrients like lutein, zeaxanthin, and omega-3 fatty acids is boosting demand.
|
Current Event |
Description and its impact |
|
Rising Digital Screen Usage |
|
|
Aging Global Population |
|
|
Increased Health and Wellness Awareness |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The growing incidences of eye diseases are a major factor leading to the high demand for eye supplements. For instance, according to data published in The Lancet, an independent, international weekly general medical journal, in October 2022, approximately 3 million people aged 40 years or older had Vision Threatening Diabetic Retinopathy (VTDR) in India with a higher prevalence in those with known diabetes residing in high and middle Epidemiological Transition Level (ETL) and Socio-demographic Index (SDI) states.
In March 2025, Nutrition Insight reported that 25% of consumers globally consider eye health their top concern related to physical well-being, according to the 2025 Trends Survey. This growing consumer focus is influencing the demand for eye health supplements.
The increasing product launches to discover newer ways to protect eyes is projected to drive the global eye health supplements market growth.
In May 2025, I-MED Pharma USA announced the launch of its dry eye product portfolio in the United States, which includes I-VU OMEGA-3 nutritional supplements. These products are aimed at providing relief for patients suffering from dry eye disease and will be sold directly to eye care professionals.
The Lutein and Zeaxanthin segment is projected to dominate the global Eye Health Supplements Market with approximately 46.3% market share in 2025. This leadership stems from their proven effectiveness in protecting against age-related macular degeneration (AMD), cataracts, and blue light-induced retinal damage. These carotenoids offer strong antioxidant and anti-inflammatory benefits, making them key ingredients in preventive eye care formulations.
Increasing consumer awareness, supported by robust clinical evidence and recommendations from eye care professionals, is driving higher adoption. The widespread use of Lutein and Zeaxanthin in both standalone supplements and combination multivitamins has further cemented their position as the most preferred ingredient type in the market.
To learn more about this report, Download Free Sample
North America is expected to retain a dominant share in the global Eye Health Supplements Market, accounting for approximately 45.6% of the market in 2025. This leading position is driven by a growing aging population susceptible to vision-related conditions such as age-related macular degeneration and cataracts. Increasing health awareness and preventive care focus among consumers are boosting supplement adoption.
The region benefits from well-established distribution channels, broad access to ophthalmic device, and strong endorsements from medical professionals. Additionally, favourable regulatory policies and continuous product innovation by major market players in the U.S. and Canada further strengthen North America’s leadership in this space.
Europe is anticipated to experience steady growth in the eye health supplements market, supported by rising public health initiatives focused on aging populations and vision care. Countries such as Germany, France, and the UK are witnessing increased consumer interest in nutraceuticals for eye wellness. Robust healthcare infrastructure, combined with regulatory support for supplement safety and efficacy, is fostering market expansion, particularly in Western Europe.
The United States and Canada dominate the North American Eye Health Supplements Market, expected to account for around 45.6% of the global share by 2025. The U.S. leads with a strong presence of key supplement manufacturers, widespread consumer awareness, and robust healthcare infrastructure supporting vision care. High prevalence of age-related eye conditions and preventive health trends drive demand for supplements.
Canada contributes through increasing health consciousness and access to ophthalmic care, supported by regulatory frameworks ensuring product safety and efficacy. Both countries benefit from continuous innovation and strategic marketing by leading brands, solidifying their leadership in the region.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3,257.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.7% | 2032 Value Projection: | USD 5,474.5 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Pfizer Inc, Bausch Health Companies Inc, Alcon, Alliance Pharma PLC, Allied Biotech Corporation, BASF SE, Amway India Enterprises Pvt. Ltd, Butterflies Healthcare Ltd, Herbalife International, Inc, Nordic Naturals, Vitabiotics Ltd, and Akorn Operating Company LLC. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
About Author
Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.
Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
